Pequeux, C. (May 2024). Estetrol combined to progesterone for menopause or contraception indication has limited effect on breast cancer growth: a preclinical study [Paper presentation]. 21th World Congress of Gynecological Endocrinology, Firenze, Italy. |
Fébrissy, C., Adlanmerini, M., Pequeux, C., Boudou, F., Buscato, M., Gargaros, A., Gilardi-Bresson, S., Boriak, K., Laurell, H., Fontaine, C., Katzenellenbogen, B. S., Katzenellenbogen, J. A., Guillermet-Guibert, J., Arnal, J.-F., Metivier, R., & Lenfant, F. (01 January 2024). Reprogramming of endothelial gene expression by tamoxifen inhibits angiogenesis and ERα-negative tumor growth. Theranostics, 14 (1), 249 - 264. doi:10.7150/thno.87306 |
Pequeux, C. (October 2023). Estetrol combined to progesterone for menopause or contraception indication has limited effect on breast cancer growth [Paper presentation]. 9th Annual MetNet International Meeting, Barcelona, Spain. |
Gallez, A., Nys, G., Wuidar, V., Dias Da Silva, I., Taziaux, M., Kinet, V., Tskitishvili, E., Noël, A., Foidart, J.-M., Piel, G., Fillet, M., & Pequeux, C. (03 June 2023). Comparison of Estetrol Exposure between Women and Mice to Model Preclinical Experiments and Anticipate Human Treatment. International Journal of Molecular Sciences, 24 (11), 9718. doi:10.3390/ijms24119718 |
Pequeux, C. (2022). Estetrol and breast cancer. In Proceedings of RRSH 2022. not applicable. |
Pequeux, C., Gallez, A., & Foidart, J.-M. (10 November 2021). Estetrol and mammary gland : friends or foes? [Paper presentation]. 14° congress of the european society of Gynecology, Venise, Italy. |
Gallez, A., Blacher, S., Maquoi, E., Konradowski, E., Joiret, M., Primac, I., Gérard, C., Taziaux, M., Houtman, R., Geris, L., Lenfant, F., Marangoni, E., Sounni, N. E., Foidart, J.-M., Noël, A., & Pequeux, C. (2021). Estetrol combined to progestogen for menopause or contraception indication is neutral on breast cancer. Cancers. doi:10.3390/cancers13102486 |
Gallez, A., BLACHER, S., Primac, I., Foidart, J.-M., & Pequeux, C. (04 March 2020). Comparison of Estradiol and Estetrol on Estrogen Receptor alpha signaling [Paper presentation]. ISGE 2020. |
Primac, I., Maquoi, E., Blacher, S., Heljasvaara, R., Van Deun, J., Smeland, H. Y. H., Canale, A., Louis, T., Stuhr, L., Sounni, N. E., Cataldo, D., Pihlajaniemi, T., Pequeux, C., De Wever, O., Gullberg, D., & Noël, A. (09 July 2019). Stromal integrin alpha11 regulates PDGFR-beta signaling and promotes breast cancer progression. Journal of Clinical Investigation, 130. doi:10.1172/JCI125890 |
Dubois, C., Rocks, N., Blacher, S., Primac, I., Gallez, A., Garcia-Caballero, M., Gérard, C., Brouchet, L., Noël, A., Lenfant, F., Cataldo, D., & Pequeux, C. (2019). Lymph/angiogenesis contributes to sex differences in lung cancer through oestrogen receptor alpha signalling. Endocrine-Related Cancer, 26 (2), 201-216. doi:10.1530/ERC-18-0328 |
Gérard, C., Gallez, A., Dubois, C., Drion, P., Delahaut, P., Quertemont, E., Noël, A., & Pequeux, C. (March 2017). Accurate Control of 17beta-Estradiol Long-Term Release Increases Reliability and Reproducibility of Preclinical Animal Studies. Journal of Mammary Gland Biology and Neoplasia, 22 (1), 1-11. doi:10.1007/s10911-016-9368-1 |
Tskitishvili, E., Pequeux, C., Munaut, C., VIELLEVOYE, R., Nisolle, M., Noël, A., & Foidart, J.-M. (2017). Estrogen receptors and estetroldependent neuroprotective actions: a pilot study. Journal of Endocrinology, 232 (1), 85-95. doi:10.1530/JOE-16-0434 |
Dubois, C., Blacher, S., García Caballero, M., Rocks, N., Pequeux, C., & Cataldo, D. (08 December 2016). Gender differences in lung tumor development: implication of estrogens [Poster presentation]. Séminaire Télévie, Bruxelles, Belgium. |
Dubois, C., Blacher, S., García Caballero, M., Rocks, N., Pequeux, C., & Cataldo, D. (09 September 2016). Gender differences in lung tumor development: implication of estrogens [Poster presentation]. Annual Mini symposium 2016, Bruxelles, Belgium. |
Carnet, O.* , Lecomte, J.* , Masset, A., Primac, I., Durré, T., Maertens, L., Detry, B., Blacher, S., Gilles, C., Péqueux, C., Paupert, J., Foidart, J.-M., Jerusalem, G., Cataldo, D., & Noël, A. (2015). Mesenchymal stem cells shed amphiregulin at the surface of lung carcinoma cells in a juxtacrine manner. Neoplasia, 17 (7), 552-63. doi:10.1016/j.neo.2015.07.002 * These authors have contributed equally to this work. |
Maertens, L., Erpicum, C., Detry, B., Blacher, S., Lenoir, B., Carnet, O., Pequeux, C., Cataldo, D., Lecomte, J., Paupert, J., & Noël, A. (2014). Bone marrow-derived mesenchymal stem cells drive lymphangiogenesis. PLoS ONE, 9 (9), 106976. doi:10.1371/journal.pone.0106976 |
Munaut, C., LORQUET, S., Pequeux, C., Coulon, C., Le Goarant, J., CHANTRAINE, F., Noël, A., GOFFIN, F., Tsatsaris, V., Subtil, D., & Foidart, J.-M. (March 2012). Differential expression of Vegfr-2 and its soluble form in preeclampsia. PLoS ONE, 7 (3), 33475. doi:10.1371/journal.pone.0033475 |
Pequeux, C., Raymond-Letron, I., Blacher, S., Boudou, F., Adlanmerini, M., Fouque, M., Rochaix, P., Noël, A., Foidart, J.-M., Krust, A., Chambon, P., Brouchet, L., Arnal, J., & Lenfant, F. (2012). Stromal Estrogen Receptor-α Promotes Tumor Growth by Normalizing an Increased Angiogenesis. Cancer Research, 72 (12), 3010-3019. doi:10.1158/0008-5472.CAN-11-3768 |
LORQUET, S., Berndt, S., Blacher, S., Gengoux, E., Peulen, O., Maquoi, E., Noël, A., Foidart, J.-M., Munaut, C., & Pequeux, C. (2010). Soluble forms of VEGF receptor-1 and -2 promote vascular maturation via mural cell recruitment. FASEB Journal, 24 (10), 3782-95. doi:10.1096/fj.09-149070 |
Lorquet, S., Pequeux, C., Munaut, C., & Foidart, J.-M. (2010). Aetiology and physiopathology of preeclampsia and related forms. Acta Clinica Belgica, 65 (4), 237-41. doi:10.1179/acb.2010.051 |
Berndt, S., Blacher, S., PERRIER d'HAUTERIVE, S., Thiry, M., Tsampalas, M., Cruz, A., Pequeux, C., LORQUET, S., Munaut, C., Noël, A.* , & Foidart, J.-M.*. (2009). Chorionic Gonadotropin Stimulation of Angiogenesis and Pericyte Recruitment. Journal of Clinical Endocrinology and Metabolism, 94 (11), 4567-74. doi:10.1210/jc.2009-0443 * These authors have contributed equally to this work. |
Lorquet, S., Berndt, S., Blacher, S., Noël, A., Munaut, C., Foidart, J.-M., & Pequeux, C. (2008). Implication of VEGF receptor soluble forms, sVEGFR-1 and sVEGFR-2, in angiogenesis. Acta Clinica Belgica, 63/1, 48-58. |
Lorquet, S., Berndt, S., Blacher, S., Noël, A., Munaut, C., Foidart, J.-M., & Pequeux, C. (2008). Implication of soluble receptors of VEGF, sVEGFR-1 and sVEGFR-2, in angiogenesis. American Journal of Reproductive Immunology, 60/1, 85. |
Munaut, C., Lorquet, S., Pequeux, C., Blacher, S., Berndt, S., Frankenne, F., & Foidart, J.-M. (2008). Hypoxia is responsible for soluble vascular endothelial growth factor receptor-1 (VEGFR-1) but not for soluble endoglin induction in villous trophoblast. Human Reproduction, 23 (6), 1407-15. doi:10.1093/humrep/den114 |
Scantamburlo, G., Hansenne, M., Fuchs, S., Pitchot, W., Marechal, P., Pequeux, C., Ansseau, M., & Legros, J.-J. (May 2007). Plasma oxytocin levels and anxiety in patients with major depression. Psychoneuroendocrinology, 32 (4), 407-410. doi:10.1016/j.psyneuen.2007.01.009 |
Keegan, B. P., Akerman, B. L., Pequeux, C., & North, W. G. (February 2006). Provasopressin expression by breast cancer cells: implications for growth and novel treatment strategies. Breast Cancer Research and Treatment, 95 (3), 265-277. doi:10.1007/s10549-005-9024-8 |
Pequeux, C., Breton, C., Hagelstein, M. T., Geenen, V., & Legros, J.-J. (November 2005). Oxytocin receptor pattern of expression in primary lung cancer and in normal human lung. Lung Cancer, 50 (2), 177-188. doi:10.1016/j.lungcan.2005.05.027 |
Hansenne, I., Rasier, G., Pequeux, C., Brilot, F., Renard, C., Breton, C., Greimers, R., Legros, J.-J., Geenen, V., & Martens, H. J. (January 2005). Ontogenesis and functional aspects of oxytocin and vasopressin gene expression in the thymus network. Journal of Neuroimmunology, 158 (1-2), 67-75. doi:10.1016/j.jneuroim.2004.08.007 |
Pequeux, C., Keegan, B. P., Hagelstein, M. T., Geenen, V., Legros, J.-J., & North, W. G. (December 2004). Oxytocin- and vasopressin-induced growth of human small-cell lung cancer is mediated by the mitogen-activated protein kinase pathway. Endocrine-Related Cancer, 11 (4), 871-885. doi:10.1677/erc.1.00803 |
Pequeux, C., Keegan, B. P., Hagelstein, M.-T., Geenen, V., North, W. G., & Legros, J.-J. (2003). Oxytocin and vasopressin autocrine/paracrine signaling in small cell lung carcinoma. International Journal of Molecular Medicine, 12/S1, 72. |
Pequeux, C., Breton, C., Hendrick, J.-C., Hagelstein, M.-T., Martens, H., Winkler, R., Geenen, V., & Legros, J.-J. (15 August 2002). Oxytocin synthesis and oxytocin receptor expression by cell lines of human small cell carcinoma of the lung stimulate tumor growth through autocrine/paracrine signaling. Cancer Research, 62 (16), 4623-4629. |
Crasson, M., Beckers, V., Pequeux, C., Claustrat, B., & Legros, J.-J. (October 2001). Daytime 50 Hz Magnetic Field Exposure and Plasma Melatonin and Urinary 6-Sulfatoxymelatonin Concentration Profiles in Humans. Journal of Pineal Research, 31 (3), 234-41. doi:10.1034/j.1600-079X.2001.310307.x |
Pequeux, C., Hendrick, J.-C., Hagelstein, M.-T., Geenen, V., & Legros, J.-J. (2001). Novel plasma extraction procedure and development of a specific enzyme immunoassay of oxytocin: application to biological and clinical investigations of small-cell carcinoma of the lung. Scandinavian Journal of Clinical and Laboratory Investigation, 61 (5), 407-415. doi:10.1080/003655101316911468 |